U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07401173) titled 'DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)' on Feb. 03.
Brief Summary: Gastric cancer is a leading cause of cancer-related mortality, and radical surgery remains the primary treatment. However, postoperative complications are common and can significantly impact patient recovery and quality of life. Currently, doctors lack precise tools to accurately predict which patients are at high risk for developing severe complications before surgery.
This study aims to validate a novel artificial intelligence (AI) model called "DeepComp." The DeepComp model integrates clinical data with advanc...